13.12.2013
- The European Commission has fined U.S. pharmaceutical producer Johnson & Johnson (J&J) €10.8 million and Swiss drugmaker Novartis of Switzerland € 5.5 million for actions taken by...
11.11.2013
- To stay competitive, pharmaceutical companies have to explore every cost-cutting opportunity. They have already made some progress by outsourcing research, development, contract...
17.04.2013
- Pharmaceutical company Actavis said on Tuesday that it would once again sell a generic version of Bayer's Yaz after an appeals court ruled that Bayer's patent for the oral...
25.03.2013
- Delays in developing copies of Roche's top-selling biotech drug are justifying the Swiss company's decision to stay out of biotech generics to focus on improved, patented versions...
29.01.2013
- Made In Austria - Austria's life science sector is renowned for sustainable growth and a lively, creative and innovative approach rooted in world-class engineering and science. As...
16.10.2012
- Watson Pharmaceuticals has won U.S. antitrust approval to buy Swiss peer Actavis on the condition that it sell a number of their current and future products to two other companies...
25.09.2012
- Pharmaceuticals - Of the many challenges inherent with biosimilar development, the inability to predict market expectations may top the list for decision makers. While uncertainty...
04.08.2012
- A divided federal appeals court overturned an order in favor of Momenta Pharmaceuticals that had blocked Watson Pharmaceuticals from selling a generic version of the blood-thinning...
